Evidence map›Paper›PMID 41273650›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Synaptic Silencing with Transactivation of Tetanus Neurotoxin for Pathway-Selective Manipulation.

Tadashi Isa, Kaoru Isa, Wim Vanduffel

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Tadashi IsaDepartment of Neuroscience, Kyoto University Graduate School of Medicine, Kyoto, Japan. isa.tadashi.7u@kyoto-u.ac.jp.
Kaoru IsaDepartment of Neuroscience, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Wim VanduffelLaboratory for Neuro-and Psychophysiology, Department of Neurosciences, KU Leuven Medical School, Leuven, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To selectively block specific brain circuits using viral vectors, two main approaches have been developed. The first involves injecting a single viral vector into the cell bodies of target neurons, followed by chemical or optogenetic stimulation at their axon terminals. The second method, known as the intersectional double viral vector technique, uses a retrograde vector injected at the axon terminals and an anterograde vector at the cell bodies of target neurons, along with systemic ligand administration. This chapter focuses on the second approach, which allows for the targeted expression of enhanced tetanus neurotoxin in specific neural pathways. This effectively disrupts their transmission by Tet transactivator system, leading to behavioral deficits in macaque monkeys. Additionally, this chemogenetic blocking technique can be combined with the DREADDs (Designer Receptors Exclusively Activated by Designer Drugs) technique to inhibit multiple pathways within a single animal. This approach has the potential to significantly advance systems neuroscience research.

Indexed as

SynapsesTetanus ToxinTranscriptional ActivationAnimalsGenetic VectorsHumansMetalloendopeptidasesNeuronsOptogeneticsSynaptic TransmissionMetalloendopeptidasestetanospasminTetanus ToxinMacaque monkeySynaptic silencingTetanus neurotoxinTet transactivator system

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.